Significance of metastamiR-10b in breast cancer therapeutics.
Apexa RavalJigna JoshiFranky D ShahPublished in: Journal of the Egyptian National Cancer Institute (2022)
The therapeutic delivery of miR-10b antagonists (antagomiRs) and/or knockdown of miRNA is beneficial in reducing tumor growth. Additionally, combination therapy which includes antisense oligonucleotides using miR-10b can function as an effective approach to tumor regression and drug resistance reversal.